A carregar...

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis

Abaloparatide (previously known as BA058) is a synthetic 34-amino acid peptide and novel selective activator of parathyroid hormone receptor 1 (PTHR1) currently under development as a new anabolic agent in the management of osteoporosis. This paper reviews the profile and potential of abaloparatide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Tella, Sri Harsha, Kommalapati, Anuhya, Correa, Ricardo
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5493470/
https://ncbi.nlm.nih.gov/pubmed/28680788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1300
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!